SBRT Treatment Planning With VMAT Versus IMRT: Impact of Duodenal Sparing on Tumor Coverage in Patients With Locally Advanced Pancreatic Adenocarcinoma

被引:0
|
作者
Kumar, R. [1 ]
Wild, A. T. [1 ]
Ziegler, M. A. [1 ]
Kang, J. [1 ]
Smith, K. S. [1 ]
Tryggestad, E. [1 ]
Ford, E. [1 ]
Wong, J. [1 ]
Hooker, T. [1 ]
Herman, J. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
10.1016/j.ijrobp.2012.07.2097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S783 / S784
页数:2
相关论文
共 50 条
  • [31] Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy
    Ilaria Trestini
    Luisa Carbognin
    Isabella Sperduti
    Clelia Bonaiuto
    Alessandra Auriemma
    Davide Melisi
    Lisa Salvatore
    Emilio Bria
    Giampaolo Tortora
    European Journal of Clinical Nutrition, 2018, 72 : 772 - 779
  • [32] Neoadjuvant chemotherapy followed by surgery versus upfront surgery in patients with borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.
    Kang, Junho
    Yoo, Changhoon
    Shin, Sang Hyun
    Kim, Kyu-Pyo
    Jeong, Jae Ho
    Chang, Heung-Moon
    Lee, Sang Soo
    Park, Do Hyun
    Song, Tae Jun
    Seo, Dong Wan
    Lee, Sung Koo
    Kim, Myung-Hwan
    Park, Jin-hong
    Hwang, Dae Wook
    Song, Ki Byung
    Lee, Jae Hoon
    Ryoo, Baek-Yeol
    Kim, Song Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [33] Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
    Kieler, Markus
    Unseld, Matthias
    Bianconi, Daniela
    Schindl, Martin
    Kornek, Gabriela V.
    Scheithauer, Werner
    Prager, Gerald W.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [34] Modified FOLFIRINOX as neoadjuvant treatment in patients with borderline resectable and locally advanced pancreatic adenocarcinoma: A single-center study
    Ioannou, S.
    Papaxoinis, G.
    Korkolis, D.
    Kypreos, D.
    Gouveris, P.
    Zouki, D.
    Kardara, V.
    Exarchos, K.
    Karianakis, G.
    Bitsas, I.
    Adamou, V.
    Koronakis, G.
    Stavrou, N.
    Demiri, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S301 - S301
  • [35] Role of FDG PET-CT in HTT treatment planning for patients with locally advanced pancreatic cancer: selection and treatment monitoring
    Picchio, M.
    Giovannini, E.
    Landoni, C.
    Passoni, P.
    Crivellaro, C.
    Reni, M.
    Bettinardi, V.
    Di Muzio, N.
    Gilardi, M. C.
    Gianolli, L.
    Messa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S223 - S223
  • [36] Feasibility of radical cardiac-sparing, treatment planning strategies for patients with locally advanced, non-small cell lung cancer
    Kim, Joshua P.
    Dewalt, Jake
    Feldman, Aharon
    Adil, Khaled
    Movsas, Benjamin
    Chetty, Indrin J.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (12):
  • [37] EXPERIENCE WITH PHOSPHORUS-32 MICROPARTICLE INTRATUMOURAL TREATMENT IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA: WAIKATO HOSPITAL - NEW ZEALAND
    Allen, Berry
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 50 - 50
  • [38] Development of extensive hepatic steatosis during treatment with nab-paclitaxel and gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma
    Vogl, U. M.
    Vormittag, L.
    Kafka, A.
    Heinrich, B.
    Roessler, L.
    Stuebler, J.
    Schima, W.
    Oehler, L.
    ONKOLOGIE, 2013, 36 : 74 - 74
  • [39] PANOVA-3: A phase 3 study of tumor-treating fields with gemcitabine and nabpaclitaxel for frontline treatment of locally advanced pancreatic adenocarcinoma
    Picozzi, Vincent J.
    Macarulla, Teresa
    Philip, Agop Philip
    Becerra, Carlos Roberto
    Dragovich, Tomislav
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] The impact of maximum tumor shrinkage of primary site by gemcitabine in the first-line treatment of metastatic and locally advanced pancreatic cancer
    Nakayama, I.
    Masato, O.
    Kei, S.
    Ikuhiro, Y.
    Takashi, S.
    Masato, M.
    Takano, K.
    Nobuyuki, M.
    Naoki, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S440 - S440